Home › Non-Small Cell Lung Cancer › Ohio › Toledo
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Toledo, OH
Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Toledo. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 2
- Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg · 8 mi ang layo
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Nagre-recruitPhase 3
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi ang layo
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Nagre-recruitPhase 1
- Site 06, Maumee · 9 mi ang layo
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Nagre-recruitPhase 3
- Taylor Cancer Research Center, Maumee · 9 mi ang layo
Pan-tumor MRD Study
Nagre-recruitObservasyonal na pag-aaral
- Taylor Cancer Research Center, Maumee · 9 mi ang layo
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Nagre-recruitPhase 3
- Research Site, Toledo
- Research Site, Maumee · 9 mi ang layo
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- Toledo Clinic Cancer Center, Toledo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi ang layo
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- Taylor Cancer Research Center, Maumee · 9 mi ang layo
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Research Site, Maumee · 9 mi ang layo
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Taylor Cancer Research Center, Maumee · 9 mi ang layo
GEMINI-NSCLC: NSCLC Biomarker Study
Nagre-recruitObservasyonal na pag-aaral
- Taylor Cancer Research Center, Maumee · 9 mi ang layo
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Nagre-recruitPhase 1/2
- Taylor Cancer Research Center (site 204), Maumee · 9 mi ang layo
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Toledo
- Kanser sa Ovary12 pag-aaral
- Kanser sa Baga11 pag-aaral
- Metastatic Cancer10 pag-aaral
- Stroke9 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg8 pag-aaral
- Kanser ng Endometrium8 pag-aaral
- Melanoma8 pag-aaral
- Kanser sa Pancreas8 pag-aaral
- Kanser sa Prostate7 pag-aaral
- Kanser sa Esophagus7 pag-aaral
- Ischemic Stroke7 pag-aaral
- Pagkabigo ng Puso7 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.